fentanyl - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DUROGESIC fentanyl 100 micrograms/h transdermal patch sachet
AUST R: 112371
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
12 Aug 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available

DUROGESIC fentanyl 12 micrograms/h transdermal patch sachet
AUST R: 116828
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
12 Aug 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available.

DUROGESIC fentanyl 25 micrograms/h transdermal patch sachet
AUST R: 112368
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
12 Aug 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available

DUROGESIC fentanyl 50 micrograms/h transdermal patch sachet
AUST R: 112369
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
12 Aug 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available

DUROGESIC fentanyl 75 micrograms/h transdermal patch sachet
AUST R: 112370
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
12 Aug 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available

APO-FENTANYL fentanyl 100 micrograms/hour transdermal drug delivery system sachet
AUST R: 152575
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
20 Dec 2024
to
21 Mar 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
An alternative generic product is available. Sponsor is working to expedite the next shipment..

DENPAX fentanyl 100 micrograms/hour transdermal patch
AUST R: 163067
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

Deletion from market:
05 Aug 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

DENPAX fentanyl 12 micrograms/hour transdermal patch
AUST R: 163066
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Alphapharm Pty Ltd

Phone:
1800 314 527

Deletion from market:
07 Aug 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

DENPAX fentanyl 25 micrograms/hour transdermal patch
AUST R: 163068
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

Deletion from market:
30 Nov 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Reduction in supply until supply is exhausted. Alternative generic products are available.

DENPAX fentanyl 50 micrograms/hour transdermal patch
AUST R: 163064
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

Deletion from market:
30 Dec 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Reduction in supply until supply is exhausted. Alternative products are available.

DENPAX fentanyl 75 micrograms/hour transdermal patch
AUST R: 163065
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

Deletion from market:
07 Aug 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

FENPATCH 12 fentanyl 12 mcg/hr transdermal patch pouch
AUST R: 143880
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Medis Pharma Pty Ltd

Phone:
+61 2 9251 1088

Deletion from market:
02 Sep 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

FENPATCH 50 fentanyl 50 mcg/hr transdermal patch pouch
AUST R: 143895
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Medis Pharma Pty Ltd

Phone:
+61 2 9251 1088

Deletion from market:
02 Sep 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

FENPATCH 75 fentanyl 75 mcg/hr transdermal patch pouch
AUST R: 143904
Active ingredients:
fentanyl

Dosage form:
Drug delivery system, transdermal

Sponsor:
Medis Pharma Pty Ltd

Phone:
+61 2 9251 1088

Deletion from market:
05 Dec 2023

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.